Inspection Record

Unilever Canada Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-03-21 12 findingsEquipment and facilityStability and storageComputer system validationLabeling and packagingOther quality systemComplaint and recall handlingRegulatory reporting and change controlDeviation, CAPA, and investigationQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The maintenance of personnel records was inadequate.

2Stability and storage

The design of the drug stability study was inadequate and/or not justified with a documented rationale.

3Stability and storage

The temperature and/or humidity control was inadequate.

4Computer system validation

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

5Labeling and packaging

The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.

6Other quality system

The assessment to release finished products was inadequate.

7Other quality system

The implementation of a self-inspection program was inadequate.

8Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

9Complaint and recall handling

The written procedures for recalls were inadequate.

10Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

11Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

12Quality unit oversight

The annual product quality review procedure was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-03-21. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Unilever Canada Inc. company profile — full history Health Canada documents, 2024 Go to Findings search